The results of the above study actually provided a new approach in distinguishing not only prostate cancer from individuals without a cancer, but also prostate cancer patients from patients with prostate benign hypertrophy (BPH), that is considered a benign inflammatory condition, but with some signs that too often may lead to a cancer over diagnosis, such as the serum PSA levels. Here, KLK3 is linked to benign prostatic hyperplasia.